Germany vs South Korea: Number of clinical trials
Germany
420
in 2024
South Korea
282
in 2024
Germany rank
11th
South Korea rank
12th
Number of clinical trials over time
- Germany
- South Korea
How they compare
Germany currently reports 420 against 282 in South Korea, a difference of 138.
That makes Germany's figure about 1.5 times South Korea's.
Across all 22 years both countries report, Germany has been ahead every year.
Germany ranks 11th and South Korea ranks 12th of 153 countries.
Germany has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Germany | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 209.29 | 56.57 | 152.71 | Germany |
| 2010s | 535.5 | 407.7 | 127.8 | Germany |
| 2020s | 488.6 | 405 | 83.6 | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, Germany or South Korea?
- Germany, at 420 against 282 in South Korea as of 2024.
- What is the difference in number of clinical trials between Germany and South Korea?
- 138, with Germany ahead.
- How many years of comparable data are there for Germany and South Korea?
- 22 years are reported by both, from 2003 to 2024.
- How do Germany and South Korea rank globally for number of clinical trials?
- Germany ranks 11th and South Korea ranks 12th of 153 countries.
- Where does this data come from?
- Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.